BiotechTube

Vesicare (solifenacin)

Phase 3Terminated
0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Overactive Bladder

Conditions

Overactive Bladder

Trial Timeline

Sep 1, 2006 → Sep 1, 2008

NCT ID
NCT00821184

About Vesicare (solifenacin)

Vesicare (solifenacin) is a phase 3 stage product being developed by Astellas Pharma for Overactive Bladder. The current trial status is terminated. This product is registered under clinical trial identifier NCT00821184. Target conditions include Overactive Bladder.

What happened to similar drugs?

20 of 20 similar drugs in Overactive Bladder were approved

Approved (20) Terminated (0) Active (0)
✅mirabegron + solifenacinAstellas PharmaApproved
✅Mirabegron + PlaceboAstellas PharmaApproved
✅SolifenacinAstellas PharmaApproved
✅SolifenacinAstellas PharmaApproved
✅Mirabegron + Tolterodine ERAstellas PharmaApproved
✅Alpha blocker + placebo + solifenacinAstellas PharmaApproved
✅Mirabegron tablet + Solifenacin tablet + Propiverine tablet + Imidafenacin tablet + Tolterodine capsuleAstellas PharmaApproved

Hype Score Breakdown

Clinical
17
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00821184Phase 3Terminated

Competing Products

20 competing products in Overactive Bladder

See all competitors
ProductCompanyStageHype Score
mirabegron + solifenacinAstellas PharmaApproved
43
Mirabegron + PlaceboAstellas PharmaApproved
43
SolifenacinAstellas PharmaApproved
43
Mirabegron + Tolterodine + Placebo to Mirabegron + Placebo to TolterodineAstellas PharmaPhase 3
40
solifenacin succinateAstellas PharmaPhase 3
40
SolifenacinAstellas PharmaPre-clinical
26
BetanisAstellas PharmaPre-clinical
26
SolifenacinAstellas PharmaApproved
43
SolifenacinAstellas PharmaPhase 2
35
Mirabegron + Tolterodine ERAstellas PharmaApproved
43
mirabegron + solifenacin + darifenacin + imidafenacin + tolterodine + oxybutynin + trospium + fesoterodine + propiverineAstellas PharmaPre-clinical
26
Alpha blocker + placebo + solifenacinAstellas PharmaApproved
43
warfarin + YM178Astellas PharmaPhase 1
29
Solifenacin succinateAstellas PharmaPhase 3
40
solifenacin succinate + tolterodineAstellas PharmaPhase 3
40
Mirabegron tablet + Solifenacin tablet + Propiverine tablet + Imidafenacin tablet + Tolterodine capsuleAstellas PharmaApproved
43
Solifenacin succinateAstellas PharmaApproved
43
Mirabegron + PlaceboAstellas PharmaPhase 3
32
SolifenacinAstellas PharmaPre-clinical
26
Solifenacin succinate + TolterodineAstellas PharmaPhase 3
40